MDxHealth
MDXH
14 hedge funds and large institutions have $28.1M invested in MDxHealth in 2023 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.
450% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 2
180% more funds holding
Funds holding: 5 → 14 (+9)
55% more capital invested
Capital invested by funds: $18.2M → $28.1M (+$9.94M)
13.98% more ownership
Funds ownership: 18.19% → 32.18% (+14%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BL
Bleichroeder LP
New York
|
+$6.85M |
| 2 |
MP
MVM Partners
Boston,
Massachusetts
|
+$4.56M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.74M |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$2.64M |
| 5 |
ABG
Ally Bridge Group
New York
|
+$2.28M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$17.5K |
| 2 |
Barclays
London,
United Kingdom
|
-$5.29K |
MDXH Hedge Fund Activity: Q1 2023 in Review
14 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in MDxHealth (MDXH) for Q1 2023, worth a combined $28.1M — up 55% from $18.2M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new MDXH positions and 2 closed out — a net gain of 9 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Bleichroeder LP, adding an estimated $6.85M. The largest seller was UBS Group, exiting entirely with an estimated $17.5K sold.
- 14 institutional investors held MDxHealth (MDXH) as of Q1 2023, up from 5 in Q4 2022.
- Funds reported $28.1M of MDxHealth stock for Q1 2023, up 55% quarter-over-quarter.
- 11 funds opened new MDxHealth positions in Q1 2023 and 2 closed out, a net change of +9 holders.
- The largest MDxHealth buyer in Q1 2023 was Bleichroeder LP, an estimated $6.85M added.
- The largest MDxHealth seller in Q1 2023 was UBS Group, an estimated $17.5K sold.
Based on aggregated 13F filings for Q1 2023.